This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
In vitro
In vivo
By sample type
Breast cancer cells (4T1)
Breast cancer cells (MDA-MB-231)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Liver cancer cells (CSQT-2)
Liver cancer cells (MHCC-97L)
Plasma
Seminal plasma
By sample status
24 hr culture
72 hr culture
Normal
Sample A_NEB
Transplant islets into mouse xenotransplantation-rejected
Vasectomy
Vasovasostomy
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
cfa-miR-1307
MIMAT0006665
1.1e-15
4.7e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000558_1
11
/
0
/
11
cfa-miR-1307
MIMAT0006665
6.4e-10
4.8e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000558_1
11
/
0
/
11
bta-miR-1307
MIMAT0009969
0.0e+0
4.0e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_1
11
/
0
/
11
cfa-miR-1307
MIMAT0006665
0.0e+0
4.5e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_1
11
/
0
/
11
ppy-miR-1307
MIMAT0016227
0.0e+0
3.9e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_1
11
/
0
/
11
bta-miR-1307
MIMAT0009969
0.0e+0
4.1e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_1
11
/
0
/
11
cfa-miR-1307
MIMAT0006665
0.0e+0
4.3e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_1
11
/
0
/
11
ppy-miR-1307
MIMAT0016227
0.0e+0
4.4e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_1
11
/
0
/
11
bta-miR-1307
MIMAT0009969
0.0e+0
4.1e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_1
11
/
0
/
11
cfa-miR-1307
MIMAT0006665
0.0e+0
4.3e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_1
11
/
0
/
11
ppy-miR-1307
MIMAT0016227
0.0e+0
4.4e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_1
11
/
0
/
11
hsa-miR-1307-5p
MIMAT0022727
0.0e+0
4.5e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000558_1
11
/
0
/
11
ppy-miR-1307
MIMAT0016227
0.0e+0
3.5e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000558_1
11
/
0
/
11
ppy-miR-1307
MIMAT0016227
0.0e+0
9.1e-3
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000558_1
11
/
0
/
11
cfa-miR-1307
MIMAT0006665
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000558_1
11
/
0
/
11
ptr-miR-1307
MIMAT0008024
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000558_1
11
/
0
/
11
hsa-miR-1307-5p
MIMAT0022727
0.0e+0
3.6e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000558_1
11
/
0
/
11
hsa-miR-1307-5p
MIMAT0022727
2.1e-2
2.1e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000558_1
11
/
0
/
11
[1]